Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,064 | 78,641 | 117,751 | 134,886 | 400,304 |
| Marketable Securities | 425,948 | 480,995 | 495,705 | 472,439 | 273,052 |
| Receivables | 215 | N/A | N/A | N/A | N/A |
| TOTAL | $499,787 | $565,657 | $622,213 | $615,698 | $685,505 |
| Non-Current Assets | |||||
| PPE Net | 29,627 | 29,720 | 30,250 | 29,074 | 24,363 |
| Investments And Advances | 0 | 0 | 3,195 | 13,798 | 0 |
| Other Non-Current Assets | 10,710 | 10,733 | 9,455 | 5,898 | 5,869 |
| TOTAL | $40,337 | $40,453 | $42,900 | $48,770 | $30,232 |
| Total Assets | $540,124 | $606,110 | $665,113 | $664,468 | $715,737 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 277 | 692 | 1,106 | 1,518 |
| Accounts payable and accrued liabilities | 3,298 | 3,988 | 2,980 | 3,288 | 3,744 |
| Accrued Expenses | 51,711 | 45,181 | 39,808 | 29,087 | 30,541 |
| TOTAL | $60,323 | $56,279 | $50,333 | $39,998 | $42,890 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,600 | 5,119 | 5,139 | 4,803 | 5,373 |
| Other Non-Current Liabilities | 192 | 216 | 284 | 88 | 131 |
| TOTAL | $60,792 | $60,535 | $61,848 | $53,597 | $48,877 |
| Total Liabilities | $121,115 | $116,814 | $112,181 | $93,595 | $91,767 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,099 | 43,950 | 43,888 | 43,837 | 43,704 |
| Common Shares | 44 | 44 | 44 | 44 | 43 |
| Retained earnings | -597,545 | -517,223 | -444,501 | -417,452 | -355,589 |
| Other shareholders' equity | -180 | -337 | -381 | -591 | -269 |
| TOTAL | $419,009 | $489,296 | $552,932 | $570,873 | $623,970 |
| Total Liabilities And Equity | $540,124 | $606,110 | $665,113 | $664,468 | $715,737 |